Vaden, R. M., Oswald, N. W., Potts, M. B., MacMillan, J. B., & White, M. A. (2017). FUSION-Guided Hypothesis Development Leads to the Identification of N(6),N(6)-Dimethyladenosine, a Marine-Derived AKT Pathway Inhibitor. Mar Drugs.

Vaden, Rachel M., Nathaniel W. Oswald, Malia B. Potts, John B. MacMillan, et Michael A. White. "FUSION-Guided Hypothesis Development Leads to the Identification of N(6),N(6)-Dimethyladenosine, a Marine-Derived AKT Pathway Inhibitor." Mar Drugs 2017.

Vaden, Rachel M., et al. "FUSION-Guided Hypothesis Development Leads to the Identification of N(6),N(6)-Dimethyladenosine, a Marine-Derived AKT Pathway Inhibitor." Mar Drugs 2017.